LISETTE PERALTA: Open Payments
NPI 1568770725 · WHITTIER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,780 in 65 payments from 10 companies in 2025. Trend: 2023 $447 · 2024 $1,991 · 2025 $2,780
Consulting: $1,320Food & beverage: $1,224Education: $236
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 6 | $1,530 |
| LEO Pharma Inc. | 18 | $264 |
| Galderma Laboratories, L.P. | 10 | $233 |
| Arcutis Biotherapeutics, Inc. | 7 | $230 |
| ABBVIE INC. | 12 | $228 |
| Janssen Biotech, Inc. | 4 | $138 |
| Incyte Corporation | 4 | $95 |
| PFIZER INC. | 2 | $40 |
| Amgen Inc. | 1 | $15 |
| Organon LLC | 1 | $6 |
Products named: DUPIXENT, Zoryve, NEMLUVIO, SKYRIZI, ANZUPGO, TREMFYA, ADBRY, OPZELURA.
Industry payments across CA — which companies pay providers there.
